XML 26 R17.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes
 9 Months Ended
Jan. 01, 2022
Income Tax Disclosure [Abstract]  
Income Taxes

10. Income Taxes

For the three months ended January 1, 2022 and December 26, 2020, the Company recorded $23.3 million and $5.3 million of income tax expense and had an effective tax rate of 25.6% and 19.7%, respectively. For the nine months ended January 1, 2022 and December 26, 2020, the Company recorded $53.7 million and $15.5 million of income tax expense and had an effective tax rate of 25.0% and 23.3%, respectively. During the three months ended December 26, 2020, the Company completed a U.S. research and development ("R&D") tax credit study for the years 2018 and 2019 that resulted in the recognition of a tax benefit of $1.7 million.

The Company’s effective tax rate for the three and nine months ended January 1, 2022 differs from the federal statutory rate of 21.0% due primarily to the effect of state and local income taxes, non-deductible expenses, tax credits, results in foreign jurisdictions, and tax benefits related to equity compensation. The Company’s effective tax rate for the three and nine months ended December 26, 2020 differs from the federal statutory rate of 21.0% due primarily to the effect of state and local income taxes, non-deductible expenses, tax credits (including the $1.7 million R&D credit), and results in foreign jurisdictions.

At January 1, 2022, the Company had no unrecognized tax benefits. The Company does not anticipate any material changes to uncertain tax benefits in the next twelve months. The Company records interest and penalties related to unrecognized tax benefits as a component of income tax expense.